These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 1409633)

  • 1. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.
    Cheng JQ; Godwin AK; Bellacosa A; Taguchi T; Franke TF; Hamilton TC; Tsichlis PN; Testa JR
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9267-71. PubMed ID: 1409633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.
    Bellacosa A; de Feo D; Godwin AK; Bell DW; Cheng JQ; Altomare DA; Wan M; Dubeau L; Scambia G; Masciullo V; Ferrandina G; Benedetti Panici P; Mancuso S; Neri G; Testa JR
    Int J Cancer; 1995 Aug; 64(4):280-5. PubMed ID: 7657393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer.
    Miwa W; Yasuda J; Murakami Y; Yashima K; Sugano K; Sekine T; Kono A; Egawa S; Yamaguchi K; Hayashizaki Y; Sekiya T
    Biochem Biophys Res Commun; 1996 Aug; 225(3):968-74. PubMed ID: 8780719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene.
    Altomare DA; Guo K; Cheng JQ; Sonoda G; Walsh K; Testa JR
    Oncogene; 1995 Sep; 11(6):1055-60. PubMed ID: 7566964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies.
    Thompson FH; Nelson MA; Trent JM; Guan XY; Liu Y; Yang JM; Emerson J; Adair L; Wymer J; Balfour C; Massey K; Weinstein R; Alberts DS; Taetle R
    Cancer Genet Cytogenet; 1996 Mar; 87(1):55-62. PubMed ID: 8646743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.
    Cheng JQ; Ruggeri B; Klein WM; Sonoda G; Altomare DA; Watson DK; Testa JR
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3636-41. PubMed ID: 8622988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas.
    Ruggeri BA; Huang L; Wood M; Cheng JQ; Testa JR
    Mol Carcinog; 1998 Feb; 21(2):81-6. PubMed ID: 9496907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a candidate oncogene SEI-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines.
    Tang TC; Sham JS; Xie D; Fang Y; Huo KK; Wu QL; Guan XY
    Cancer Res; 2002 Dec; 62(24):7157-61. PubMed ID: 12499249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome mapping of the mouse Akt2 gene and Akt2 pseudogene.
    Altomare DA; Kozak CA; Sonoda G; Testa JR
    Cytogenet Cell Genet; 1996; 74(4):248-51. PubMed ID: 8976376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of homogeneously staining regions in non-Hodgkin lymphomas.
    Arranz E; Robledo M; Martínez B; Gallego J; Román A; Rivas C; Benítez J
    Cancer Genet Cytogenet; 1996 Mar; 87(1):1-3. PubMed ID: 8646732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2.
    Mitsuuchi Y; Johnson SW; Sonoda G; Tanno S; Golemis EA; Testa JR
    Oncogene; 1999 Sep; 18(35):4891-8. PubMed ID: 10490823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of AKT3, encoding a member of the Akt/protein kinase B family, to human and rodent chromosomes by fluorescence in situ hybridization.
    Murthy SS; Tosolini A; Taguchi T; Testa JR
    Cytogenet Cell Genet; 2000; 88(1-2):38-40. PubMed ID: 10773662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer.
    Yuan ZQ; Sun M; Feldman RI; Wang G; Ma X; Jiang C; Coppola D; Nicosia SV; Cheng JQ
    Oncogene; 2000 May; 19(19):2324-30. PubMed ID: 10822383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis.
    Cheng JQ; Altomare DA; Klein MA; Lee WC; Kruh GD; Lissy NA; Testa JR
    Oncogene; 1997 Jun; 14(23):2793-801. PubMed ID: 9190895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms.
    Nakayama K; Nakayama N; Kurman RJ; Cope L; Pohl G; Samuels Y; Velculescu VE; Wang TL; Shih IeM
    Cancer Biol Ther; 2006 Jul; 5(7):779-85. PubMed ID: 16721043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells.
    Liu AX; Testa JR; Hamilton TC; Jove R; Nicosia SV; Cheng JQ
    Cancer Res; 1998 Jul; 58(14):2973-7. PubMed ID: 9679957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SH2-like Akt homology (AH) domain of c-akt is present in multiple copies in the genome of vertebrate and invertebrate eucaryotes. Cloning and characterization of the Drosophila melanogaster c-akt homolog Dakt1.
    Franke TF; Tartof KD; Tsichlis PN
    Oncogene; 1994 Jan; 9(1):141-8. PubMed ID: 8302573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma.
    Staal SP
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):5034-7. PubMed ID: 3037531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line.
    Chang K; Pastan I
    Int J Cancer; 1994 Apr; 57(1):90-7. PubMed ID: 8150545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma.
    Kannan K; Coarfa C; Chao PW; Luo L; Wang Y; Brinegar AE; Hawkins SM; Milosavljevic A; Matzuk MM; Yen L
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1272-7. PubMed ID: 25733895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.